Sonrotoclax is a potent, orally active Bcl2 inhibitor. Sonrotoclax has effective cell killing effect against a variety of lymphoma and leukemia cell lines[1].
Molecular Weight:
890.10
Purity:
99.61
CAS Number:
[2383086-06-2]
Formula:
C49H59N7O7S
Target:
Bcl-2 Family
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted